Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

株式のランク #4343
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
株価
$2.43
時価総額
$3.63B
変化(1日)
0.48%
変化(1年)
-9.81%
国
CN
取引 Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

カテゴリー

Healthcare
Zhejiang Huahai Pharmaceutical Co., Ltd.(600521)の配当利回りの履歴
Zhejiang Huahai Pharmaceutical Co., Ltd.(銘柄コード: 600521)の配当利回り(TTM)は2023-12-31時点で2.60%です。
過去5年間の平均配当利回り: 1.32%
Zhejiang Huahai Pharmaceutical Co., Ltd.(600521)の2000から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 0.61% -66.67%
2024 1.83% -29.62%
2023 2.60% 453.19%
2022 0.47% -48.91%
2021 0.92% 15.00%
2020 0.80% -13.04%
2019 0.92% -62.60%
2018 2.46% 219.48%
2017 0.77% -10.47%
2016 0.86% 24.64%
2015 0.69% -59.41%
2014 1.70% 25.00%
2013 1.36% 6.25%
2012 1.28% 34.74%
2011 0.95% 79.25%
2010 0.53% -43.01%
2009 0.93% -6.06%
2008 0.99% 17.86%
2007 0.84% 600.00%
2006 0.12% -97.82%
2005 5.51% 250.96%
2004 1.57% -50.16%
2003 3.15% 178.76%
2002 1.13% -45.41%
2001 2.07% 0.00%
2000 0.00% 0.00%
類似企業または競合他社の配当利回り(TTM)